A £4 million investment fund, backed by University College London, will help scientists exploit the human genome.
The Bloomsbury BioSeed Fund has been formed by a six-strong consortium of biomedical research centres including University College London, the Cancer Research Campaign, Imperial Cancer Research Fund, Institute of Cancer Research, London School of Pharmacy and the Royal Veterinary College.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber? Login